Wakefield Asset Management Lllp Johnson & Johnson Transaction History

Wakefield Asset Management Lllp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 25, 2024	SELL	$145.6 - $158.88 $837,928 - $914,354	-5,755 Reduced 35.22%	10,586 $1.66 Million
Q3 2023 Nov 01, 2023	BUY	$155.75 - $174.48 $2.12 Million - $2.38 Million	13,612 Added 498.79%	16,341 $2.55 Million
Q2 2023 Jul 31, 2023	SELL	$154.35 - $166.11 $771 - $830	-5 Reduced 0.18%	2,729 $451,000
Q1 2023 May 02, 2023	BUY	$151.05 - $180.26 $412,970 - $492,830	2,734 New	2,734 $423,000
Q3 2019 Oct 25, 2019	SELL	$126.95 - $142.14 $187,378 - $209,798	-1,476 Closed	0 $0
Q2 2019 Aug 13, 2019	SELL	$131.15 - $144.24 $123,543 - $135,874	-942 Reduced 38.96%	1,476 $206,000
Q1 2019 May 06, 2019	BUY	$125.72 - $139.79 $11,440 - $12,720	91 Added 3.91%	2,418 $338,000
Q4 2018 Feb 15, 2019	SELL	$122.84 - $147.84 $7,370 - $8,870	-60 Reduced 2.51%	2,327 $300,000
Q3 2018 Nov 15, 2018	BUY	$121.58 - $142.88 $290,211 - $341,054	2,387 New	2,387 $330,000

4,275

1.68B

17.6M

14.5M

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $379B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

Get notified when there are updates to the investment portfolio of Wakefield Asset Management Lllp, based on Form 13F filings with the SEC.

Stay updated on Wakefield Asset Management Lllp with notifications on news.